Table 2.
Characteristics of the primary tumor, treatment, and recurrence of patients in Group 1.
| N (%) | |
|---|---|
| Primary tumor | |
| Lymphoproliferative disease | 8 (25.8%) |
| Skin non-melanoma tumor | 1 (3.2%) |
| Lung cancer | 3 (9.6%) |
| Occult lung cancer (diagnosis on native lung) | 10 (32.3%) |
| Head and neck cancer | 2 (6.5%) |
| Colon cancer | 5 (16.2%) |
| Uterine cancer | 1 (3.2%) |
| Prostatic cancer | 1 (3.2%) |
| Oncological Treatment | |
| Surgery | 11 (35.5%) |
| Surgery + CT | 1 (3.2%) |
| Surgery + CT + RT | 2 (6.5%) |
| CT | 2 (6.5%) |
| CT + RT | 1 (3.2%) |
| CT + RT + bone marrow transplant | 2 (6.5%) |
| Bone marrow transplant | 3 (9.6%) |
| Follow-up | 9 (29.0%) |
| Cancer recurrence | 5 (16.1%) |
CT: chemotherapy; RT: radiotherapy.